Mereo BioPharma Group

MREONasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$45.008 M

$0.29 -4.26%

Close of 21 Sept 2026

Revenue

$500.0K

#3534 by revenue

Earnings

$41.9M

#1636 by earnings

Shares outstanding

798,454,864

Latest filing cover page

P/E ratio

1.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#354Elicio TherapeuticsELTX$50.2M
#355Werewolf TherapeuticsHOWL$47.6M
#356Mereo BioPharma GroupMREO$45.0M
#357Grace TherapeuticsGRCE$44.2M
#358ScynexisSCYX$43.8M

What if Mereo BioPharma Group were worth as much as…

Open the what-if tool →

Gold $30.3T

$195,133.17

Per share 672,641× higher

Bitcoin $1.72T

$11,085.09

Per share 38,211× higher

Nvidia $5.48T

$35,320.74

Per share 121,754× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Mereo BioPharma Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.